Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. Its primary therapeutic areas include virology, oncology, and inflammatory diseases, with specific focus on treatments for HIV and hepatitis C.
The company operates in over 35 countries and employs more than 17,000 people worldwide. It invests billions in research and development annually to support its drug discovery and commercialization pipeline.
Gilead maintains partnerships, pricing initiatives, and patient assistance programs globally as part of efforts to expand access to its treatments. The company's stated focus includes addressing global health challenges and working to dismantle health inequities.
